PHARMCO II ApS: Financial statements 2019
CVR: 25202899
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PHARMCO II ApS (CVR 25202899) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -19,125 and a net result of DKK 1,488,499 compared with DKK 1,682,250 the year before. Equity in the 2019 report amounted to DKK 66,886,676. The solvency ratio was 90.9%.
- Gross Profit
- DKK -19,125
- Profit/Loss
- DKK 1,488,499
- Equity
- DKK 66,886,676
- Total Assets
- DKK 73,547,599
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -19 t. | 1.5 mio. | 66.9 mio. | - |
| 2018 | - | -19 t. | 1.7 mio. | 61.2 mio. | - |
| 2017 | - | -18 t. | 2.8 mio. | 59.5 mio. | - |
| 2016 | - | -21 t. | 2.3 mio. | 56.7 mio. | - |
| 2015 | - | 17.8 mio. | 3 mio. | - | 37 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PHARMCO II ApS has published its annual report for 2018. Gross profit came to DKK -18,749, and the net result was DKK 1,682,250.
About PHARMCO II ApS
PHARMCO II ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK -56,000 and a net result of DKK 34,432,000 compared with DKK 7,096,622 the year before. Equity in the 2025 report amounted to DKK 107,079,000.